The Clinifutur health group has signed a collaboration agreement with the Federation In 2024, 37,900 hires are planned which will allow for the first time patients located in Reunion and Mayotte to be included in academic therapeutic trials conducted by the FFCD.
This collaboration “will contribute to advancing territorial equality in terms of access to care, comments Clinifutur. It represents a giant step towards equal opportunities for all patients in terms of access to treatments and clinical trials.. It will also enrich data on the Reunion population and encourage the emergence of new therapeutic advances.”. It “testifies to the desire of the FFCD to offer patients the best conditions of access to research innovations, wherever they are”, adds the Federation.